This is a 9-month Phase 2, randomized, double-blind, placebo-controlled,
multicenter study to assess the efficacy and safety of daily treatment with OM-85 compared to placebo, when given on top of standard of care treatment, in reducing wheezing events (WEs) during the 6-month Treatment period in children aged 6 months to 5 years with previous recurrent WEs.

Question Title

* 1. Please enter your name for us to contact you.

Question Title

* 2. Please enter a phone number for us to contact you.

Question Title

* 3. Is your child aged six months to five years old?

Question Title

* 4. How frequently does your child use an inhaler or a medication such as montelukast or zafirlukast?

Question Title

* 5. How many times did your child have a wheezing or asthma event in the last 12 months?

Question Title

* 6. Is your child up to date on their vaccinations according to the CDC's guidelines?

Question Title

* 7. Does your child have any known physical respiratory tract abnormalities?

Question Title

* 8. Is your child's wheezing known to be caused by gastroesophageal reflux?

Question Title

* 9. Does your child have any other known chronic respiratory diseases?

Question Title

* 10. Does your child have an autoimmune disease or deficiency?

Question Title

* 11. Does your child have any other major medical issues?

Question Title

* 12. Was your child born prematurely, before 34 weeks?

Question Title

* 13. Does your child have cancer, or any other malignancy?

Question Title

* 14. Is your child taking any steroids such as prednisolone?

Question Title

* 15. Has your child taken immunosuppressants, immunostimulants, or gamma
globulins within the last 6 months?

Question Title

* 16. Has your child had a major surgery in the last three months?

T